Aliso Viejo, CA – According to filings with the U.S. Securities and Exchange Commission, Okami Medical is raising $7,200,001.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Robert Rosenbluth played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Okami Medical

Okami Medical, Inc. is a privately held medical device company with a mission to address the evolving needs of patients and physicians through the development of innovative, versatile, and intuitive devices for the occlusion of peripheral vessels. Okami designed the LOBO Vascular Occlusion System to allow physicians to access and rapidly occlude a wide range of vascular targets. The company was created in 2017 by Inceptus Medical, a medical device incubator. Okami is backed by members of the board of directors, U.S. Venture Partners (USVP) and medical device industry veterans.

To learn more about Okami Medical, visit http://okamimedical.com/

Contact:
Robert Rosenbluth, Chief Executive Officer
949-446-9710
https://www.linkedin.com/in/bob-rosenbluth-50558115/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved